Ganymed Pharmaceuticals

Contact
ganymed-pharmaceuticals.com
+4961311440-100

Ganymed Pharmaceuticals AG

Freiligrathstrasse 12
55131 Mainz
Germany
+4961311440-100
ganymed-pharmaceuticals.com
Contact
Profile Products News
Contact

About Ganymed Pharmaceuticals

GANYMED Pharmaceuticals AG is a leading biopharmaceutical company offering smart antibody therapeutics for ideal targets in solid cancers.

Read more about Ganymed Pharmaceuticals
Facts about Ganymed Pharmaceuticals
  • Focus : Manufacturer
  • Employees: 51-200
  • Industry : Pharma

Product portfolio of Ganymed Pharmaceuticals

Product portfolio

Show all

News about Ganymed Pharmaceuticals

Ganymed Pharmaceuticals

30-May-2014 | research and development

Ganymed’s IMAB362 Shows Strong Evidence of Single-Agent Activity in Phase IIa Trial in Gastroesophageal Cancer

Ganymed Pharmaceuticals AG announced that its Ideal Monoclonal Antibody IMAB362 demonstrated significant safety and therapeutic benefits in a Phase IIa ...

Read news
Ganymed Pharmaceuticals

06-Aug-2010 | research and development

Clinical Phase I Results of GANYMED's iMAB362 Antibody Demonstrate Excellent Safety

A clinical first-in-human Phase I multi center study with GANYMED's monoclonal antibody iMAB362 demonstrated excellent safety up to a dosis of 1g/sqm in ...

Read news
Ganymed Pharmaceuticals

13-Oct-2006 | people

Dr. Thomas M. Rinderknecht chairs Supervisory Board of GANYMED

GANYMED Pharmaceuticals AG announced the appointment of Dr. Thomas M. Rinderknecht as new Chairman of the Supervisory Board and the election of Dr. Alfred ...

Read news
Ganymed Pharmaceuticals

10-Apr-2006 | research and development

GANYMED lead antibodies show excellent efficacy and safety in mouse tumor models

GANYMED Pharmaceuticals AG announced that several monoclonal lead antibodies directed against the company's GC182 cancer target have shown excellent ...

Read news
Show more news about Ganymed Pharmaceuticals

Here you will find Ganymed Pharmaceuticals AG